Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Integra LifeSciences Holdings Corporation

Market Cap 1.37B 1.19B 1.1B 1.03B 1.94B 129B 1.95B 13.1B 5.08B 63.52B 5.13B 5.02B 221B P/E 2026 *
27x
P/E 2027 * 14.7x
Enterprise Value 2.71B 2.36B 2.19B 2.05B 3.84B 255B 3.86B 25.92B 10.05B 126B 10.16B 9.94B 436B EV / Sales 2026 *
1.61x
EV / Sales 2027 * 1.47x
Free-Float
72.35%
Yield 2026 *
-
Yield 2027 * -
1 day+2.21%
1 week-1.07%
Current month+9.60%
1 month+14.23%
3 months+96.64%
6 months+38.97%
Current year+41.55%
1 week 17.09
Extreme 17.09
18.3
1 month 14.74
Extreme 14.74
18.3
Current year 8.7
Extreme 8.7
18.3
1 year 8.7
Extreme 8.7
18.3
3 years 8.7
Extreme 8.7
46.75
5 years 8.7
Extreme 8.7
76.7
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 2026-04-30
Director of Finance/CFO 54 2023-06-27
Chief Tech/Sci/R&D Officer - 2026-02-16
Director TitleAgeSince
Chairman 64 2012-01-02
Director/Board Member 81 1991-12-31
Director/Board Member 65 2005-12-31
Date Insider Type Main position Quantity % Market Cap.
05-31Free

Executive/Senior Manager

92,281 0.1186%
05-31Free

Chief Executive Officer

1,070,765 1.3758%
05-08Tax

Director

-882 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
+2.21%-1.07%+51.55%-56.76% 1.37B
-0.10%+0.26%-33.52%-17.14% 154B
+1.54%-1.07%-8.11%-10.79% 102B
-4.45%+3.12%+61.36%+57.49% 56.51B
-1.90%-3.49%-7.43%+47.34% 52.89B
+1.67%-1.55%-14.51%-43.86% 39.67B
-1.32%-1.83% - - 30.39B
+1.74%-3.85%-9.41%-44.24% 27.96B
+1.35%-0.26%+51.96%-10.42% 23.17B
-1.53%+1.14%-15.21%-5.72% 20.35B
Average -0.08%-1.13%+8.52%-9.35% 50.79B
Weighted average by Cap. -0.26%-1.23%-5.83%-2.92%

Financials

2026 *2027 *
Net sales 1.68B 1.46B 1.35B 1.27B 2.38B 158B 2.39B 16.05B 6.22B 77.83B 6.29B 6.16B 270B 1.73B 1.51B 1.4B 1.31B 2.46B 163B 2.47B 16.59B 6.43B 80.43B 6.5B 6.36B 279B
Net income 42.73M 37.26M 34.51M 32.3M 60.58M 4.03B 60.95M 409M 159M 1.98B 160M 157M 6.89B 74.56M 65.01M 60.21M 56.37M 106M 7.04B 106M 714M 277M 3.46B 280M 274M 12.02B
Net Debt 1.34B 1.17B 1.08B 1.01B 1.9B 126B 1.91B 12.82B 4.97B 62.16B 5.02B 4.92B 216B 1.18B 1.03B 950M 889M 1.67B 111B 1.68B 11.27B 4.37B 54.62B 4.41B 4.32B 190B
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
26-06-18 17.58 $ +2.21% 2,322,863
26-06-17 17.20 $ -2.88% 791,527
26-06-16 17.71 $ +1.43% 862,006
26-06-15 17.46 $ -1.74% 891,566
26-06-12 17.77 $ +1.48% 534,402
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
17.58USD
Average target price
17.43USD
Spread / Average Target
-0.86%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IART Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!